AtrayeeBasu MallickMD
Oncology • Philadelphia, PAGastrointestinal Cancer, Hematologic Oncology, Sarcoma
, Medical Oncology, Thomas Jefferson University Hospital
Dr. Basu Mallick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1015 Chestnut St
Ste 1321
Philadelphia, PA 19107Phone+1 215-923-5676Fax+1 215-923-7390
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2007 - 2010
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2004 - 2007
Medical College and Hospital KolkataClass of 2000
Certifications & Licensure
NJ State Medical License 2017 - 2025
PA State Medical License 2010 - 2024
DE State Medical License 2017 - 2019- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
- Award for Outstanding Service and Dedication Kings County Hospital, 2007
- Intern of the Year SUNY Downstate, 2005
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsEffect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarc...Brandon M Huffman, Atrayee Basu Mallick, Nora K Horick, Andrea Wang-Gillam, Peter Joel Hosein
JAMA Network Open. 2023-01-03 - Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocol.Amy L Shaver, Nikita Nikita, Swapnil Sharma, Daniel S Lefler, Atrayee Basu-Mallick
BMJ Open. 2022-07-21 - 13 citationsThe Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review.Amy L Shaver, Swapnil Sharma, Nikita Nikita, Daniel S Lefler, Atrayee Basu-Mallick
Cancers. 2021-12-18
Journal Articles
- Pazopanib for the Treatment of Soft Tissue Sarcoma - Where Does It Fit?Mallick, Atrayee Basu; Narasimhan, Vivek; Soman, Neelesh; Chawla, Sant P, Journal of OncoPathology, 1/1/2014
- PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS...Arjun Sood, Danielle McClain, Radhashree Maitra, Atrayee Basu-Mallick, Raviraja Seetharam, Andreas Kaubisch, Lakshmi Rajdev, John M. Mariadason, Kathryn Tanaka, Sanjay..., Clinical Colorectal Cancer, 1/1/2012
- Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell linesAtrayee Basu Mallick MD, Raviraja Seetharam Phd, Arjun Sood MD, Sanjay Goel MD, Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 1/1/2010
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
